Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19304988 | 0.92 | LMNA (0.61) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL8720778 | 0.92 | LMNA (0.61) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL1867849 | 0.81 | — | — | |
| SCHEMBL6935516 | 0.81 | — | — | |
| SCHEMBL29508718 | 0.78 | LMNA (0.50) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL23497716 | 0.74 | LMNA (0.53) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL6435544 | 0.74 | TSHR (0.33) | ALDH1A1 | |
| SCHEMBL23497770 | 0.74 | LMNA (0.53) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5146599 | 0.74 | LMNA (0.53) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3089641 | 0.74 | LMNA (0.53) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307846-A | Organic-inorganic hybridized nano clay and preparation method and application thereof | 合肥中科科乐新材料有限责任公司 | 2024-07-09 | — | — | CN | claimed |
| US-9644140-B2 | Method of reducing dust with particulates coated with a polycationic polymer | BAKER HUGHES INCORPORATED (US) | 2017-05-09 | — | — | US | claimed |
| US-9624377-B2 | Methods of using sand composites to control dust | BAKER HUGHES INCORPORATED (US) | 2017-04-18 | — | — | US | claimed |
| US-20150104647-A1 | SAND COMPOSITES AND METHODS OF USING THE SAME TO CONTROL DUST | BAKER HUGHES HOLDINGS LLC | 2015-04-16 | — | — | US | claimed |
| US-20150047848-A1 | METHOD OF REDUCING DUST WITH PARTICULATES COATED WITH A POLYCATIONIC POLYMER | BAKER HUGHES HOLDINGS LLC | 2015-02-19 | — | — | US | claimed |
| US-6232469-B1 | FOR DYES, POLYMERS | FUJI PHOTO FILM CO., LTD. (JP) | 2001-05-15 | — | — | US | claimed |
| US-5981600-A | Hydroxyanthraquinone derivatives | BAYKUT FIKRET (TR) | 1999-11-09 | — | — | US | claimed |
| EP-0369944-A1 | Substituted oxadiamino butanes | CIBA-GEIGY AG (CH) | 1990-05-23 | — | — | EP | claimed |
| CN-118307846-A | Organic-inorganic hybridized nano clay and preparation method and application thereof | 合肥中科科乐新材料有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024076715-A1 | METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-01-18 | — | — | US | disclosed |
| CN-115996751-A | Methods and compositions relating to ionic liquid adjuvants | 哈佛大学校长及研究员协会 | 2023-04-21 | — | — | CN | disclosed |
| US-20230102247-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-03-30 | — | — | US | disclosed |
| EP-4142787-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | President And Fellows Of Harvard College (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-0691327-A1 | AMINE DERIVATIVE AND DERMATOLOGIC PREPARATION CONTAINING THE SAME | Kao Corporation (JP) | 1996-01-10 | — | — | EP | disclosed |
| EP-0605543-A1 | COMPOSITION FOR EXTERNAL SKIN CARE. | KAO CORP (JP) | 1994-07-13 | — | — | EP | disclosed |
| WO-1993005763-A1 | COMPOSITION FOR EXTERNAL SKIN CARE | KAO CORPORATION (JP) | 1993-04-01 | — | — | WO | disclosed |
| US-5169867-A | Antitumor agents, anticarcinogenic agents | CIBA-GEIGY CORPORATION (US) | 1992-12-08 | — | — | US | disclosed |
| EP-0452264-A1 | Hydroxylamine compounds | CIBA-GEIGY AG (CH) | 1991-10-16 | — | — | EP | disclosed |
| EP-0369944-A1 | Substituted oxadiamino butanes | CIBA-GEIGY AG (CH) | 1990-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | LMNA 725/4885L3MBTL1 167/4885TDP1 2194/4885 |
| US-20230102247-A1 | METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS | MYD88, TLR7, TLR9 | LMNA 1658/4885L3MBTL1 1368/4885TDP1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.